Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Leukemia|August 1, 1997
TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemiaS Takeuchi, T Seriu, C R Bartram, et al.
Blood Cancer Journal|April 8, 2017
Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patientsS Thiant, M M Moutuou, P Laflamme, et al.
Leukemia|March 27, 2009
PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitorsS Wojiski, F C Guibal, T Kindler, et al.
Cancer|December 24, 1997
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute ConsortiumL B Silverman, T W McLean, R D Gelber, et al.
Bone Marrow Transplantation|December 12, 2002
Unrelated bone marrow transplantation for leukocyte adhesion deficiencyN J Farinha, M Duval, E Wagner, et al.
American Journal of Hematology|December 1, 1992
Cytogenic characterization of primary refractory anemiaM Gyger, G D'Angelo, R Bélanger, et al.
American Journal of Hematology|September 23, 1997
Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphomaR D Legare, J G Gribben, M Maragh, et al.
ESMO Open|August 8, 2025
Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK BiobankM Sun, L Busque, J Sandoval, et al.
Blood|November 24, 2001
The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathwaysD W Sternberg, M H Tomasson, M Carroll, et al.
Blood|February 9, 2000
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study GroupJ A Thompson, D G Gilliland, J T Prchal, et al.
Pageof 10